1.24Open1.71Pre Close54 Volume237 Open Interest82.00Strike Price4.20KTurnover38.19%IV2.36%PremiumMay 9, 2025Expiry Date0.00Intrinsic Value100Multiplier3DDays to Expiry0.68Extrinsic Value100Contract SizeAmericanOptions Type0.3371Delta0.1261Gamma112.18Leverage Ratio-0.1784Theta0.0023Rho37.81Eff Leverage0.0277Vega
Merck & Co Stock Discussion
For the revenue consensus estimate, analysts anticipate revenue around $15.48 billion, which would be a slight decrease of about 1.9% year-over-year.
Wall Street expects Merck to report EPS of approximately $2.16. This would r...
Landmark Trial: Merck's New PAH Drug Shows Stunning 76% Reduction in Life-Threatening Events
No comment yet